Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Mazzaro

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Hepatology (Baltimore, Md.)|February 3, 2000
Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosisC Merkel, R Marin, D Sacerdoti, et al.
Italian Journal of Gastroenterology and Hepatology|March 26, 1999
Cryoglobulinaemic membranoproliferative glomerulonephritis and hepatitis C virus infectionC Mazzaro, G Pozzato, F Zorat, et al.
Reumatismo|September 25, 2008
[Fibronectin gene polymorphisms and clinical manifestations of mixed cryoglobulinemic syndrome: increased risk of lymphoma associated to MspI DD and HaeIII AA genotypes]M Fabris, L Quartuccio, V De Re, et al.
Lancet (London, England)|December 21, 1996
Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Gruppo-Triveneto per L'ipertensione portale (GTIP)C Merkel, R Marin, E Enzo, et al.
Haematologica|April 11, 2000
Peripheral blood neutrophils from hepatitis C virus-infected patients are replication sites of the virusM Crovatto, G Pozzato, F Zorat, et al.
Italian Journal of Gastroenterology and Hepatology|August 1, 1997
Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapyC Mazzaro, G S Carniello, R Colle, et al.
British Journal of Haematology|September 1, 1996
Hepatitis C virus and non-Hodgkin's lymphomasC Mazzaro, V Zagonel, S Monfardini, et al.
European Journal of Gastroenterology & Hepatology|January 1, 1996
Optimizing the time-frame for the definition of bleeding-related death after acute variceal bleeding in cirrhosisC Merkel, A Gatta, A Bellumat, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 6, 2007
Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virusV De Re, L Caggiari, S De Vita, et al.
Arthritis and Rheumatism|December 8, 2011
A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitisS De Vita, L Quartuccio, M Isola, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Hepatology (Baltimore, Md.)|February 3, 2000
Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosisC Merkel, R Marin, D Sacerdoti, et al.
Italian Journal of Gastroenterology and Hepatology|March 26, 1999
Cryoglobulinaemic membranoproliferative glomerulonephritis and hepatitis C virus infectionC Mazzaro, G Pozzato, F Zorat, et al.
Reumatismo|September 25, 2008
[Fibronectin gene polymorphisms and clinical manifestations of mixed cryoglobulinemic syndrome: increased risk of lymphoma associated to MspI DD and HaeIII AA genotypes]M Fabris, L Quartuccio, V De Re, et al.
Lancet (London, England)|December 21, 1996
Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Gruppo-Triveneto per L'ipertensione portale (GTIP)C Merkel, R Marin, E Enzo, et al.
Haematologica|April 11, 2000
Peripheral blood neutrophils from hepatitis C virus-infected patients are replication sites of the virusM Crovatto, G Pozzato, F Zorat, et al.
Italian Journal of Gastroenterology and Hepatology|August 1, 1997
Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapyC Mazzaro, G S Carniello, R Colle, et al.
British Journal of Haematology|September 1, 1996
Hepatitis C virus and non-Hodgkin's lymphomasC Mazzaro, V Zagonel, S Monfardini, et al.
European Journal of Gastroenterology & Hepatology|January 1, 1996
Optimizing the time-frame for the definition of bleeding-related death after acute variceal bleeding in cirrhosisC Merkel, A Gatta, A Bellumat, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 6, 2007
Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virusV De Re, L Caggiari, S De Vita, et al.
Arthritis and Rheumatism|December 8, 2011
A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitisS De Vita, L Quartuccio, M Isola, et al.
Pageof 5